Research programme: cyclin-dependent kinase inhibitors - Banyu

Drug Profile

Research programme: cyclin-dependent kinase inhibitors - Banyu

Alternative Names: cyclin-dependent kinase inhibitors research programme - Banyu

Latest Information Update: 12 Feb 2008

Price : $50

At a glance

  • Originator Banyu
  • Class
  • Mechanism of Action Cyclin-dependent kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 17 Sep 2004 No development reported - Preclinical for Cancer in Japan (unspecified route)
  • 19 Sep 2001 Preclinical development for Cancer in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top